Home
About Us
Timeline
Milestones
Management Team
Infrastructure
Manufacturing Facilities
R&D Facility
Quality Control Lab
Products
FIP
Diabetix
Markets
Global Presence
CSR
Sustainability
Ethics & Compliance Program
Careers
Contact Us
Franco-Indian (Segments & Products)
MONLEVO JUNIOR
®
Tablets
Composition:
Each uncoated bilayered dispersible tablet contains :
Montelukast Sodium I.P.equivalent to Montelukast..
4 mg
Levocetirizine Dihydrochloride I.P.
2.5mg
Excipients
q.s.
Colour: yellow oxide of iron,Erythrosine ( C.I.No.45430)
Indications:
For the relief and/or prevention of symptoms associated with:
-
Intermittent Allergic Rhinitis and Persistent Allergic Rhinitis
-
Allergic rhinitis associated with asthma.
Contact Us
|
Privacy Policy
Copyright © 2017. Franco-Indian Pharmaceuticals Pvt. Ltd.